United States · Health Care · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Bluejay Diagnostics, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -117.02% | -290.39% | 152.47% | 60.4% | 37.68% | 27.43% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -99.42% | -155.98% | -361.51% | -361.61% | -361.88% | -362.91% |
| Total Assets | $7,119,237.00 | $1,954,362.00 | $1,954,362.00 | $1,954,362.00 | $1,954,362.00 | $1,954,362.00 |
| Sector average | $3,280,499,225.95 | $3,298,345,309.75 | $3,676,894,011.56 | |||
| Net Income | -$6,848,483.00 | -$7,076,626.16 | -$7,065,146.19 | -$7,067,145.77 | -$7,072,510.37 | -$7,092,573.82 |
| $4,262,561,283.40 |
| $4,994,412,918.01 |
| $5,761,557,240.51 |